Table 1.
Dataset | Platform | Control /SCZ | Female(%) | Medication Status | Genes Analyzed | Ethnicity or Origin |
---|---|---|---|---|---|---|
GSE1831245 | Affymetrix Human Exon 1.0 ST Array | 8+13 | 33 | Medicated | 17,131 | San Diego and Taiwan |
GSE2738346 | Affymetrix Human Genome U133 Plus 2.0 Array | 29+43 | NA | Mix | 21,826 | Multi-ethnic groups |
GSE3848147 | Illumina HumanRef-8_V3 beadchip | 22+15 | 27 | Mix | 12,647 | Denmark and Netherland |
GSE3848447 | Illumina HumanHT-12_V3 beadchip | 96+106 | 42 | Mix | 17,233 | Denmark and Netherlands |
GSE4807248 | Illumina HumanHT-12_V4 beadchip | 31+35 | 53 | NA | 15155 | Finland, Sweden, Caucasian |
GSE5491349 | Arraystar Human LncRNA microarray V2.0 | 12+18 | NA | Treatment naive | 13,003 | Han Chinese |
Kumarasinghe et al 201350 | Illumina HumanHT-12_V3 beadchip | 11+10 | 38 | Treatment naive | 10,544 | Sinhalese |
Notes: The “Mix” medication status indicates that the participants with and without drug treatment were part of the study. While “NA” (not available) indicates the unavailability of information on medication status.